LGBTQ+ Patients Face Widespread Discomfort and Discrimination in Healthcare, New Study Finds
NEW YORK, May 19, 2025 /PRNewswire/ -- Navigating the U.S. healthcare system is challenging for many, but for LGBTQ+ individuals, it can be even more daunting. A new nationwide study by the team at Bespoke Surgical is revealing that LGBTQ+ patients face disproportionately high rates of discrimination, discomfort, and mistrust in medical settings.
The study, which surveyed over 1,500 Americans, found that 1 in 5 LGBTQ+ patients feel uncomfortable sharing their sexual orientation or gender identity with their doctor—a rate eight times higher than that of straight patients. The discomfort is even more pronounced for non-binary individuals, 40% of whom report unease in disclosing their identities.
Key Findings Include:
71% of LGBTQ+ patients say they've felt judged by a healthcare provider, compared to 42% of straight patients.
Nearly half (49%) of LGBTQ+ respondents say their health concerns have been dismissed by a doctor.
81% of LGBTQ+ patients worry that new federal policies could reduce access to LGBTQ+-specific healthcare services.
78% say they'd feel more comfortable with a doctor who shares their sexual orientation, highlighting the need for increased representation in healthcare.
The study also explored how comfort—or lack thereof—shapes honesty in healthcare. Over one-third of LGBTQ+ respondents (36%) admitted to lying to their doctor, compared to just 16% of straight respondents. The reasons? Fear of judgment, stigma, and assumptions from providers remain top barriers to honest conversations about health, especially around topics like sexual history, drug use, and mental health.
"Transparency can be lifesaving in the medical world. Because of this, it is crucial that patients trust their doctors and feel understood," says Dr. Evan Goldstein, founder of Bespoke Surgical. "It is clear for LGBTQ+ people this is not always the case – many feel judged and uncomfortable with their available medical practices, leading to dishonesty."
Despite the challenges, LGBTQ+ individuals remain proactive in seeking affirming care. Over half (54%) are willing to go out of network to find inclusive providers, and one in three say it's difficult to find affirming care in their area, particularly in states like South Carolina, Texas, Missouri, and Tennessee.
The study also sheds light on topics patients are most and least comfortable discussing. While most respondents are open about diet, exercise, and alcohol use, far fewer feel comfortable discussing sexual kinks, anal health, or overall satisfaction with their sex life—especially among LGBTQ+ patients.
What Would Help?
LGBTQ+ respondents identified several solutions that would make healthcare feel safer and more accessible in 2025:
Stronger anti-discrimination protections (68%)
More inclusive healthcare networks with affirming providers (60%)
LGBTQ+-specific training for medical professionals (54%)
Legal protections for gender-affirming care (51%)
To find more interesting insights, please visit the complete study.
About Bespoke Surgical
Headquartered in New York City, Bespoke Surgical is a leading sexual health and wellness practice. Founded in 2010 by Dr. Evan Goldstein, Bespoke Surgical caters to a wide range of clients, with a majority of patients being LGBTQ+. Learn more at: BespokeSurgical.com.
Media Contact
Greg Lam
(212) 206-1501
View original content to download multimedia:https://www.prnewswire.com/news-releases/lgbtq-patients-face-widespread-discomfort-and-discrimination-in-healthcare-new-study-finds-302457976.html
SOURCE Bespoke Surgical
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Vytanutra Launches Sustained Release Vitamin C with Iron for Daily Immune Support
IRVINE, Calif., June 12, 2025 /PRNewswire/ -- Vytanutra proudly announces the release of its newest product, Vytanutra C, Ascorbic Acid a scientifically formulated supplement designed to deliver consistent immune and support Collagen Synthesis throughout the day. This advanced formula features Sustained-release Pellet technology, paired with Iron, and is made to meet the needs of modern wellness seekers. Each capsule delivers a steady supply of Vitamin C to help maintain healthy immune function, support collagen production, and provide ongoing protection against oxidative stress. Enhanced with Sustained release coating technology, the beadlets are designed for gradual release and optimal stability, helping preserve potency and ensure consistent absorption over time. Key Features: • Extended-Release Pellet System – The spherical pellet is designed to enlarge the absorption area in the GI tract and deliver Vitamin C steadily for 12 hours, helping maintain a stable plasma concentration in the blood. • Non-GMO, Vegan, and Gluten-Free – Clean and conscious formulation suitable for various dietary needs Each bottle contains 90 Pellet capsules, making it a convenient and reliable choice for individuals seeking daily immune system support with long-lasting effects. Now Available on AmazonVisit the Vytanutra Amazon Store and search "Vytanutra C" to explore the latest in immune support innovation. Stay strong. Stay resilient. Experience all-day wellness with Vytanutra Immune Support Vitamin C. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Contact:Sean TangAccount Manager396609@ View original content to download multimedia: SOURCE Vytanutra
Associated Press
27 minutes ago
- Associated Press
Lumeris Partners with Google Cloud to Address the U.S. Primary Care Shortage
Unique collaboration brings the best of AI, cloud computing, primary care expertise and proven solutions to help solve one of healthcare's most intractable problems ST. LOUIS, June 12, 2025 /PRNewswire/ -- Lumeris, a leader in healthcare technology and services, and Google Cloud today announced a partnership to improve access to high-quality primary care in the United States by building Lumeris' Tom™ platform on Google Cloud technology. The collaboration targets a growing gap, where annual demand for care exceeds 2.5 billion hours, but less than 500 million hours are available, according to Lumeris estimates. 'AI is transforming healthcare in new and profound ways, including expanding access to more people,' said Thomas Kurian, CEO, Google Cloud. 'By combining Google Cloud's AI capabilities with Lumeris' decades of primary care insight, we can provide doctors and nurses with the AI support and insights they need to help improve care for their patients.' Built by Lumeris and powered by Google Cloud's AI models and infrastructure, Tom is the industry's most advanced AI-powered Primary Care as a Service™ solution, acting as a proactive care team member embedded directly in clinical workflows to autonomously execute best next actions that expand capacity, improve access and reduce administrative burdens in primary care. 'The human toll of the primary care shortage is staggering—missed diagnoses, delayed treatments, and inferior outcomes,' said John Doerr, chairman of Kleiner Perkins, and board member of Lumeris. " More than 100 million Americans lack access to primary care, and another 100 million are receiving suboptimal care. Now, two world-class companies — Google and Lumeris—are bringing their unique capabilities together to help solve this crisis. We have both the means and the resolve to dramatically improve care for hundreds of millions of Americans.' Highlights of the Google Cloud and Lumeris partnership: 'Tom is designed to be the best partner and care team member a physician could ever have,' said Mike Long, chairman and CEO of Lumeris. 'Under the complete supervision of the physician, Tom is embedded in primary care workflows, autonomously executing the best next action with appropriate guardrails for each patient—performing hundreds of tasks from checking-in on patients, to scheduling screenings and monitoring medications, to conducting outreach and escalating issues. Healthcare delivery as we have known it for generations is now fundamentally changed forever.' Lumeris working with Google Cloud and other partners means Tom's capabilities will remain current with the accelerating pace of AI innovation, ensuring Tom's users are deploying the most advanced, highest value Primary Care as a Service capabilities. About Tom Tom is the industry's most advanced AI-powered Primary Care as a Service solution, acting as a proactive care team member embedded directly in clinical workflows to autonomously execute best next actions that expand capacity, improve access and reduce administrative burdens in primary care. Built on more than two decades of health care experience and five years of AI development, Tom enables personalized, effective and scalable care delivery for providers and patients nationwide. Named in honor of the late Dr. Tom Doerr, a Lumeris founder and champion of patient-centered primary care, Tom embodies his vision of expanding access and improving health care through innovation. To learn more, visit About Lumeris Founded in 2012, Lumeris has pioneered primary care-led, value-based care transformation, partnering with health systems and physician practices nationwide to implement tailored models that improve quality and reduce costs. Using Tom, its AI-driven technology platform, Lumeris is achieving the industry's best quality metrics, better patient experiences, and enhanced physician satisfaction across Medicare Advantage, Traditional Medicare, Medicaid, and Commercial populations. Its Medicare Advantage plan, Essence Healthcare, consistently earns 4.5 to 5.0 star ratings from the Centers for Medicare and Medicaid Services. Lumeris employs 1,200 engineers, healthcare specialists, and clinicians across offices in St. Louis and Boston and generated $3 billion in revenues in 2024. For more information, visit View original content to download multimedia: SOURCE Lumeris
CNN
29 minutes ago
- CNN
New federal Covid-19 vaccine policies are already keeping some people from getting shots
After federal health officials made abrupt changes to US Covid-19 vaccine recommendations for pregnant women last month, there's new confusion and uncertainty about who can get the shots — and some reports that patients were turned away when they tried to get vaccinated. Now, 30 health and medical organizations are pushing for continued access and insurance coverage for the vaccines. 'We are deeply concerned about the recently adopted HHS policy to no longer recommend COVID-19 vaccination during pregnancy,' wrote the organizations – including major professional groups for obstetricians, primary care providers, pediatricians, pharmacists and nurses – in an open letter. 'It is vital that we ensure that pregnant women continue to have access to this prevention tool so that they can protect themselves and their young infants, a vulnerable group who is not yet eligible for vaccination.' The letter calls on 'payers and insurers to continue making the COVID-19 vaccine available to pregnant people without undue utilization management or cost-sharing requirements,' even though the shots have been removed from the list of vaccines recommended by the US Centers for Disease Control and Prevention. Pregnant women who have Covid-19 are more likely to require care in the ICU or on a ventilator, or to die, the letter said, and they're at higher risk of complications such as cesarean birth, preeclampsia or eclampsia, and blood clots. Infants born after a Covid-19 infection also face increased risks. The letter comes two weeks after US Health and Human Services Secretary Robert F. Kennedy Jr. abruptly announced that the Covid-19 vaccine, which has shown to be safe and effective during pregnancy, would no longer be recommended for pregnant people. Leaders from the US Food and Drug Administration also recently outlined a new framework for the approval process for Covid-19 vaccines that could limit shots to older Americans and people at higher risk of serious Covid-19 infection. Experts immediately warned that these changes could create new barriers to vaccines for those who want them, including confusion around who is eligible and higher costs for patients if insurance no longer covers them. The American Pharmacists Association, which signed on to the open letter, said it has already received reports of patients being denied Covid-19 vaccines. Leigh Haldeman, 33, a nurse at Harborview Medical Center in Seattle who is pregnant, told CNN that she tried twice to get vaccinated last week and was turned away. 'Because of some complications I had during my first pregnancy, getting the vaccine now and getting that extra boost of immunity would be definitely important for me,' said Haldeman, who got her last shot in the fall of 2024. At two different pharmacies, she was told it is not recommended for pregnant women to receive the Covid-19 vaccine, based on new guidelines. She still hasn't been able to get the shot. Many doctors still strongly recommend Covid-19 vaccination during pregnancy. 'Despite the change in recommendations from HHS, the science has not changed,' the American College of Obstetricians and Gynecologists said in a statement. 'It is very clear that COVID-19 infection during pregnancy can be catastrophic and lead to major disability, and it can cause devastating consequences for families. The COVID-19 vaccine is safe during pregnancy, and vaccination can protect our patients and their infants after birth.' After an appointment last week, Haldeman agreed with her obstetrician's advice to get an additional Covid-19 shot during her pregnancy. Her first try was a Walgreens store where she had an appointment to get the vaccine. 'I went through the whole check-in process, and then as soon as the pharmacist saw that I was pregnant, they were like, 'We cannot give this to you,' ' she recounted. ' 'We're only giving it to immunocompromised people right now.' ' She said she asked whether she was considered immunocompromised because she's pregnant. Haldeman said the pharmacist responded that guidelines have changed, that it's not recommended and they wouldn't give it to her. She then called her primary care provider and obstetrician, but neither had the vaccine in stock. In past years, pharmacies have administered the majority of Covid-19 shots. A Walgreens spokesperson told CNN, 'We continue to closely monitor and review all federal and state guidance related to vaccines. As regulations and recommendations evolve, we remain committed to ensuring our pharmacy teams have the latest information to support patient care.' Haldeman said her obstetrician suggested trying another pharmacy. She called a Safeway and asked, 'I'm 25 weeks pregnant. My provider is recommending that I get this Covid booster. Are you able to give that to me?' The immediate answer was no. 'I'm under the impression from my provider that I need to get this,' she recalled saying. 'Pharmacies are the only people that appear to have it right now. What do I need to do to get this vaccine?' She said the pharmacist told her, 'The guidelines have changed as of last Friday. We can't give it to you.' The pharmacist suggested that Haldeman try getting a prescription for the vaccine from her provider so the pharmacy might be able to administer it. Her obstetrician wrote a vaccination prescription and sent it to the Safeway pharmacy, but when Haldeman visited the location at 7 p.m. the same day, she was told the pharmacy hadn't received the prescription. In a statement from a company spokesperson, Safeway parent company Albertsons told CNN, 'In accordance with recently updated CDC guidance, we adjusted our COVID-19 vaccination policies. Pregnant individuals with specific medical conditions that increase their risk of severe illness remain eligible for vaccination. We encourage all customers to consult with their healthcare providers for personalized advice.' The lack of clarity left Haldeman frustrated and uncertain about what to do next. 'I spent half my day on this. … Most people are probably not going to go to those lengths to get the vaccine. The more hoops that you make people jump through, less and less people are just going to get vaccinated,' Haldeman said. 'And we know that having Covid during pregnancy does terrible things to your placenta, and certainly reducing that risk is worth it. So it's very frustrating.' The American Pharmacists Association said in a news release that the updates to the Covid-19 recommendations 'do not appear to be based on the scientific evidence provided over the past few years. … COVID-19 vaccination during pregnancy has been proven safe and effective.' However, pharmacists 'may face consequences if they do not follow the Advisory Committee on Immunization Practices or CDC recommendations,' said Allison Hill, the association's director of professional affairs. 'HHS's and CDC's recent changes to the Covid-19 recommendations create barriers and confusion,' Hill said. HHS's unusual updates to the Covid-19 vaccine schedules were followed this week by a sweeping change to the CDC's Advisory Committee on Immunization Practices, the independent experts who typically guide the agency on its vaccine recommendations. Kennedy bypassed ACIP in making the Covid-19 changes and then said this week that he had dismissed the entire 17-member panel. On Wednesday, Kennedy announced eight new members to ACIP. The removal of the vaccine advisers sparked a swift backlash from health care providers and professional organizations. Dr. Tina Tan, president of the Infectious Diseases Society of America, another organization that signed the open letter, said that undermining the integrity of ACIP is 'completely unfounded' and has 'a significant negative impact on Americans of all ages.' The pharmacists association said Tuesday, 'It is highly concerning that removing 17 scientists overnight eliminates the historical knowledge, scientific training, and clinical expertise required to equip pharmacists and the public to make appropriate choices for health based upon the risk.' Since Kennedy announced changes to the Covid-19 vaccine schedule, doctors said they're worried about their patients and the future of vaccinations. 'We are worried about our patients in the future, who may be less likely to choose vaccination during pregnancy despite the clear and definitive evidence demonstrating its benefit,' Dr. Steven J. Fleischman, president of the American College of Obstetricians and Gynecologists, said in a statement. 'We are concerned about access implications and what this recommendation will mean for insurance coverage of the COVID-19 vaccine for those who do choose to get vaccinated during pregnancy. And as ob-gyns, we are very concerned about the potential deterioration of vaccine confidence in the future.' Studies have shown that infants who are born after a Covid-19 infection during pregnancy are at increased risk of stillbirth, respiratory distress and low birth weight. 'With maternal health being compromised, you have the risk for preterm delivery, babies that are born very small or potentially even fetal loss early on,' Dr. Flor Munoz-Rivas, an associate professor of pediatrics and infectious disease at Baylor College of Medicine, said last week. Dr. John Lynch, an associate medical director at the Harborview Medical Center and a colleague of Haldeman's, said Covid-19 vaccination during pregnancy also has benefits for the newborn. 'Vaccinating a mom leads to the protection of the baby when they don't have their own immune response,' Lynch said. Since the Covid vaccine is not available to babies younger than 6 months, vaccinating the mother may be the safest way for young children to gain some immunity. 'That first year of life remains the highest period of risk, and this is a vaccine-preventable disease,' Muñoz said. 'We can modify the outcomes for these babies through maternal vaccination and through infant vaccination.'
